Showing results (31-40 of 160) with videos related to

Sort By:
Pageof 16
Drug Discovery Today|May 10, 2012
Read-through therapy for mitochondrial DNA nonsense mutationsDavid Pacheu-Grau, Aurora Gómez-Durán, Ester López-Gallardo, et al.
Clinical Immunology (Orlando, Fla.)|April 21, 2006
Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individualsCarlos Julio Montoya, Paula Andrea Velilla, Claire Chougnet, et al.
Journal of Reproductive Immunology|October 22, 2011
In vitro human immunodeficiency virus and sperm cell interaction mediated by the mannose receptorWalter Cardona-Maya, Paula A Velilla, Carlos Julio Montoya, et al.
Journal of Alzheimer'S Disease : JAD|July 16, 2014
OXPHOS, pyrimidine nucleotides, and Alzheimer's disease: a pharmacogenomics approachAlba Pesini, Eldris Iglesias, Nuria Garrido, et al.
Plos One|January 26, 2012
HIV-induced T-cell activation/exhaustion in rectal mucosa is controlled only partially by antiretroviral treatmentCesar Mauricio Rueda, Paula Andrea Velilla, Claire A Chougnet, et al.
Drug Discovery Today|November 30, 2010
Mitochondrial pharma-Q-genomics: targeting the OXPHOS cytochrome bAurora Gómez-Durán, David Pacheu-Grau, Manuel J López-Pérez, et al.
Biochimica Et Biophysica Acta|October 9, 2008
20 years of human mtDNA pathologic point mutations: carefully reading the pathogenicity criteriaJulio Montoya, Ester López-Gallardo, Carmen Díez-Sánchez, et al.
Drug Discovery Today|November 4, 2009
Mitochondrial pharmacogenomics: barcode for antibiotic therapyDavid Pacheu-Grau, Aurora Gómez-Durán, Manuel J López-Pérez, et al.
Stem Cell Research|January 1, 2022
Generation of an induced pluripotent stem cell line from a compound heterozygous patient in TK2 geneCarmen Hernández-Ainsa, Andrés Nascimento, Cristina Jou, et al.
Pageof 16